Overview
Studies in my laboratory concern the immunological properties of DNA as related to two main topics: 1) the induction of anti-DNA responses in systemic lupus erythematosus; and 2) the stimulation of innate immunity by bacterial DNA. These topics are closely linked since we have established novel disease models in which lupus-like illness can be induced in normal mice by bacterial DNA under conditions in which mammalian DNA is inactive. This model has been useful in elucidating mechanisms of DNA antigen drive in autoimmunity.
To pursue these studies, our laboratory conducts investigations in the following areas: 1) specificity of anti-DNA for epitopes on mammalian and bacterial DNA; 2) molecular analysis of murine monoclonal anti-DNA antibodies; 3) histopathological analyses of DNA-immunized mice; 4) in vitro analysis of proliferation, antibody production and cytokine expression in human and murine immune cells; and 5) analysis of DNA binding to cell surface molecules on B cells, T cells and macrophages. Results of these studies have allowed identification of at least two structural motifs that are immunoactive. We are also exploring the impact of chemical modifications of the DNA backbone.
In addition to work on the immunology of DNA, I am also involved in clinical trials related to new immunomodulatory agents in the treatment of rheumatoid arthritis as well as serological markers of disease activity.
The areas of research for which I am known nationally are anti-DNA antibodies, systemic lupus erythematosus and immunological properties of DNA. I have written textbook chapters and reviews on all these subjects.
To pursue these studies, our laboratory conducts investigations in the following areas: 1) specificity of anti-DNA for epitopes on mammalian and bacterial DNA; 2) molecular analysis of murine monoclonal anti-DNA antibodies; 3) histopathological analyses of DNA-immunized mice; 4) in vitro analysis of proliferation, antibody production and cytokine expression in human and murine immune cells; and 5) analysis of DNA binding to cell surface molecules on B cells, T cells and macrophages. Results of these studies have allowed identification of at least two structural motifs that are immunoactive. We are also exploring the impact of chemical modifications of the DNA backbone.
In addition to work on the immunology of DNA, I am also involved in clinical trials related to new immunomodulatory agents in the treatment of rheumatoid arthritis as well as serological markers of disease activity.
The areas of research for which I am known nationally are anti-DNA antibodies, systemic lupus erythematosus and immunological properties of DNA. I have written textbook chapters and reviews on all these subjects.
Current Appointments & Affiliations
Professor of Medicine
·
1990 - Present
Medicine, Rheumatology and Immunology,
Medicine
Professor of Integrative Immunobiology
·
1994 - Present
Integrative Immunobiology,
Basic Science Departments
Member of the Duke Cancer Institute
·
1978 - Present
Duke Cancer Institute,
Institutes and Centers
Member of the Duke Human Vaccine Institute
·
2014 - Present
Duke Human Vaccine Institute,
Institutes and Centers
Recent Publications
Highlights from the 2024 Rheumatoid Arthritis Research Summit.
Journal Article Semin Arthritis Rheum · February 2025 Full text Link to item CiteThe Limitation of HLA Diversity as a Risk Factor for Pediatric-Onset Autoimmune Rheumatic Disease.
Journal Article J Clin Med · January 30, 2025 Background: HLA homozygosity of specific alleles at a single locus is associated with increased risk for autoimmunity and/or more severe clinical phenotypes. However, the contribution of the overall limitation of HLA diversity across multiple loci to autoi ... Full text Link to item CitePerspectives of Rheumatologists on the Type 1 and 2 Systemic Lupus Erythematosus Model.
Journal Article ACR Open Rheumatol · December 2024 OBJECTIVE: The Type 1 and 2 systemic lupus erythematosus (SLE) Model was developed to encapsulate all signs and symptoms that patients with SLE experience. Our previous qualitative work demonstrated the model accurately reflects the lived experience of peo ... Full text Link to item CiteRecent Grants
Complement activating properties of anti-Sm/RNP antibodies in SLE
ResearchCo Investigator · Awarded by Department of Defense · 2024 - 2026Improving Quality of Life in SLE by Stratified Personalized Health Planning
ResearchCo Investigator · Awarded by Department of Defense · 2022 - 2026Engineered DNA-particles to model immune events in systemic lupus erythematosus
ResearchCo-Principal Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2023 - 2025View All Grants
Education, Training & Certifications
Yeshiva University, Albert Einstein College of Medicine ·
1973
M.D.
Yeshiva University, Albert Einstein College of Medicine ·
1972
Ph.D.